Assessing the effects of probiotic supplementation in patients with metastatic melanoma on checkpoint-inhibitor therapy

被引：0
|
作者：
Vujevic, Andro [1 ]
Strikic, Dominik [1 ]
Plese, Sven [1 ]
Cegec, Ivana [1 ]
Turk, Viktorija Erdeljic [1 ]
Ausperger, Ksenija Makar [1 ]
Mikulic, Iva [1 ]
Aumiler, Matea Radacic [1 ]
Likic, Robert [1 ]
Mercep, Iveta [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0926
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [41] The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Krieger, Penina
    Sanchez-Vega, Francisco
    Schultz, Nikolaus
    Shoushtari, Alexander
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [42] Immune checkpoint inhibitor treatment of advanced age metastatic melanoma (MM) patients.
    Hegde, Upendra P.
    Kerr, Phil
    Masternak, Sophie
    Brenner, Bruce Mark
    Grant-Kels, Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
    Andrew Patterson
    Noam Auslander
    Nature Communications, 14
  • [44] Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy
    Pickering, Chad
    Aiyetan, Paul
    Xu, Gege
    Mitchell, Alan
    Rice, Rachel
    Najjar, Yana G. G.
    Markowitz, Joseph
    Ebert, Lisa M. M.
    Brown, Michael P. P.
    Tapia-Rico, Gonzalo
    Frederick, Dennie
    Cong, Xin
    Serie, Daniel
    Lindpaintner, Klaus
    Schwarz, Flavio
    Boland, Genevieve M. M.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] Peritoneal melanosis associated with metastatic melanoma previously treated with targeted and immune checkpoint inhibitor therapy
    Sim, Kwang Kiat
    Connell, Katie
    Bhandari, Mayank
    Paton, David
    BMJ CASE REPORTS, 2021, 14 (01)
  • [46] Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma A case report
    Langan, Ewan A.
    Budner, Kaja
    Zillikens, Detlef
    Terheyden, Patrick
    MEDICINE, 2021, 100 (16) : E25513
  • [47] CHECKPOINT INHIBITOR IMMUNOTHERAPY INDUCED HEPATOTOXICITY IN PATIENTS WITH METASTATIC MELANOMA: THE NORTHERN IRELAND EXPERIENCE
    McIlwaine, Stuart
    Gregory, Rebecca
    McCartney, Therese
    Forde, Caroline
    O'Neill, Conor
    Braniff, Conor
    Cash, Johnny
    Oladipo, Bode
    GUT, 2021, 70 : A147 - A148
  • [48] Breathless Battle: Unmasking Immune Checkpoint-inhibitor Pneumonitis in Cancer Patients A Case Series
    Peralta De Avila, A.
    Torres-Cardenas, C.
    Torres, B. B.
    Oropeza Martinez, V.
    Villegas Lopez, C.
    Esperon Zapata, C.
    Juarez Leon, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [49] Hyperprogression in Pediatric Melanoma Metastatic to the Breast Treated with a Checkpoint Inhibitor
    Bernal Vaca, Laura
    Mendoza, Sara D.
    Vergel, Juan C.
    Rueda, Xavier
    Bruges, Ricardo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)
  • [50] Managing checkpoint inhibitor induced inflammatory arthritis in metastatic melanoma
    Nordmann, T.
    Micaletto, S.
    Braun, R.
    Barysch, M.
    Dummer, R.
    Mangana, J.
    SWISS MEDICAL WEEKLY, 2018, 148 : 21S - 21S
12345